Recent Press Releases

X-Chem Announces Collaboration with Janssen and Johnson & Johnson Innovation to Advance Novel Candidates to Treat Inflammatory Diseases

--X-Chem to Identify Small Molecule Leads Using its Proprietary Discovery Engine Fueled by a DNA-Encoded Library Exceeding 100 Billion Compounds-- WALTHAM, Mass.--X-Chem, Inc....

AMRI to Acquire Aptuit Drug Product Development and Aseptic Clinical Manufacturing Businesses

ALBANY, N.Y., Jan. 9, 2015 -- AMRI (NASDAQ: AMRI) today announced that it has acquired the outstanding equity interests of Aptuit's Glasgow, UK business and has entered into a definitive...

Evotec and Ohio State to collaborate on novel cancer therapy

*Collaboration leverages the breadth & experience of Evotec's drug discovery infrastructure *Efforts will explore the use of a novel approach, discovered at Ohio State, for targeting mutant...

WuXi Launches Mobile App to Enable Chemistry-on-the-Go

SHANGHAI, Jan. 5, 2015 -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading open-access R&D capability and technology platform company serving the pharmaceutical, biotechnology and medical...

PPD and SNBL Announce Japanese Clinical Development Joint Venture and Additional Collaborations

WILMINGTON, N.C. & TOKYO--Pharmaceutical Product Development, LLC (PPD) and Shin Nippon Biomedical Laboratories Ltd. (SNBL) (TSE:2395) today announced an agreement to form a joint venture that...

WIL Research Partners with Instem for Global Harmonization Project

CONSHOHOCKEN, Pa. -- Instem, a leading provider of IT solutions to the global early development healthcare market, announced today that WIL Research has placed an expanded order for the deployment of...

X-Chem Licenses Cardiovascular Drug Discovery Program to Bayer Pharma AG

--- Second license granted to Bayer within a year--- WALTHAM, Mass.--X-Chem, Inc., a privately held biotechnology company focused on applying its innovative drug discovery capabilities to the...

Achievement of multiple milestones in Evotec's drug discovery alliances

Hamburg, Germany - Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) disclosed today that it achieved multiple milestones in ongoing alliances with its strategic research...

KCR Acquires Project Portfolio from Ukrainian CRO AXIS

WARSAW, Poland--KCR, a European Contract Research Organization (CRO), has recently acquired the whole portfolio of clinical projects from the Ukrainian CRO, AXIS Group Ltd. The acquisition of AXIS...

PPD and ERT Establish Strategic Partnership to Enhance Drug Development

WILMINGTON, N.C., and PHILADELPHIA – Pharmaceutical Product Development, LLC (PPD) and ERT today announced a strategic partnership to facilitate delivery of ERT's comprehensive solutions...

WuXi Opening Offices in Boston and San Francisco

SHANGHAI -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading open-access R&D capability and technology platform company serving the pharmaceutical, biotechnology and medical device industries,...

CRO Health Decisions Names Industry Veteran Stephen DeCherney, MD, MPH, Interim CEO

Durham, North Carolina. Health Decisions, Inc., the full-service clinical research organization of choice for forward-looking biopharma and medical device companies, today announced the appointment...

BioClinica Names Dr. John Hubbard Chief Executive Officer

NEWTOWN, Pa. -- BioClinica®, Inc., a leading provider of specialty outsourced clinical trial services, announced today that it has appointed John Hubbard, Ph.D., FCP, as chief executive officer...

Health Decisions Provides Response to Inquiries Regarding the Business Impact of the December 8th Tragic Accident

Durham, North Carolina--As we mourn the loss of our CEO, Michael Rosenberg, MD, MPH, and five others in Maryland Monday, December 8, Health Decisions' day-to-day site, clinical and business...

Statement on the Death of Health Decisions' CEO Michael Rosenberg, MD, MPH

Durham, North Carolina--Health Decisions confirms with deep regret and great sadness that founder and CEO Michael Rosenberg, MD, MPH, died at approximately 11:00 a.m. December 8, 2014 in a private...

DaVita Clinical Research and HealthCare Partners Clinical Research to Merge and Expand Clinical Trials and Data Analytics Capabilities

MINNEAPOLIS, Dec. 15, 2014 -- DaVita HealthCare Partners Inc. (NYSE: DVA), one of the nation's largest and most innovative health care communities, today announced that two of its business units,...

Medidata Announces Availability of Patient Profiles Offering

NEW YORK--Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced the availability of its enriched solution for risk-based...

Medidata Announces Availability of Patient Profiles Offering

NEW YORK--Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced the availability of its enriched solution for risk-based...

X-Chem and Alexion Collaborate to Discover Novel Therapeutic Candidates to Treat Patients with Severe and Ultra-Rare Disorders

WALTHAM, Mass.--X-Chem, Inc., a biotechnology company focused on the generation of novel small molecule therapeutics using its proprietary DNA-encoded library platform, today announced the initiation...

BBK Worldwide, ACRES Partnership Brings Patient Centricity to Alliance's Clinical Industry Standard Efforts

BOSTON, MA--BBK Worldwide, a leading clinical trial marketing firm, and the Alliance for Clinical Research Excellence and Safety (ACRES), an Alliance-driven non-profit organization operating in the...